Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34 + progenitors
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Variants in ETV6, which encodes a transcription repressor of the E26 transformation-specific family, have recently been reported to be responsible for inherited thrombocytopenia and hematologic malignancy. We sequenced the DNA from cases with unexplained dominant thrombocytopenia and identified six likely pathogenic variants in ETV6, of which five are novel. We observed low repressive activity of all tested ETV6 variants, and variants located in the E26 transformation-specific binding domain (encoding p.A377T, p.Y401N) led to reduced binding to corepressors. We also observed a large expansion of megakaryocyte colony-forming units derived from variant carriers and reduced proplatelet formation with abnormal cytoskeletal organization. The defect in proplatelet formation was also observed in control CD34+ cell-derived megakaryocytes transduced with lentiviral particles encoding mutant ETV6. Reduced expression levels of key regulators of the actin cytoskeleton CDC42 and RHOA were measured. Moreover, changes in the actin structures are typically accompanied by a rounder platelet shape with a highly heterogeneous size, decreased platelet arachidonic response, and spreading and retarded clot retraction in ETV6 deficient platelets. Elevated numbers of circulating CD34+ cells were found in p.P214L and p.Y401N carriers, and two patients from different families suffered from refractory anemia with excess blasts, while one patient from a third family was successfully treated for acute myeloid leukemia. Overall, our study provides novel insights into the role of ETV6 as a driver of cytoskeletal regulatory gene expression during platelet production, and the impact of variants resulting in platelets with altered size, shape and function and potentially also in changes in circulating progenitor levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Bejar, R., Stevenson, K., Abdel-Wahab, O., Galili, N., Nilsson, B., Garcia-Manero, G., Kantarjian, H., Raza, A., Levine, R. L., Neuberg, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013343 · Cited by 1,627 · cited 1×
“Somatic ETV6 variants have also been found in solid tumors, T-cell leukemias and myelodysplastic syndromes, hence the widespread interest in this gene.(5,6) ETV6 encodes an E26 transformation-specific (Ets) family transcriptional repressor.”
Recurrent R-spondin fusions in colon cancer
Seshagiri, S., Stawiski, E. W., Durinck, S., Modrusan, Z., Storm, E. E., Conboy, C. B., Chaudhuri, S., Guan, Y., Janakiraman, V., Jaiswal, B. S., et al. (2012) · Nature · doi:10.1038/nature11282 · Cited by 960
Raslova, H., Komura, E., Le Couédic, J. P., Larbret, F., Debili, N., Feunteun, J., Danos, O., Albagli, O., Vainchenker, W., & Favier, R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21197 · Cited by 174 · cited 1×
“Lentiviral particle production and CD34 cell transduction Lentiviral particles were prepared as previously described.(21,22) CD34 cells were infected twice.”
Self-citationTEL Is a Sequence-specific Transcriptional Repressor
Lopez, R. G., Carron, C., Oury, C., Gardellin, P., Bernard, O., & Ghysdael, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30132 · Cited by 174 · cited 1×
“humans, is often found fused with partner genes in samples from human leukemia of myeloid and lymphoid origin.(4) Somatic ETV6 variants have also been found in solid tumors, T-cell leukemias and myelodysplastic syndromes, hence the widespread interest in this gene.”
TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3
Wang, L., & Hiebert, S. W. (2001) · Oncogene · doi:10.1038/sj.onc.1204479 · Cited by 101
DNA Binding by the ETS Protein TEL (ETV6) Is Regulated by Autoinhibition and Self-association
Green, S. M., Coyne, H. J., McIntosh, L. P., & Graves, B. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.096958 · Cited by 69 · cited 1×
“The central region is involved in repressive complex recruitment (including SMRT, Sin3A and NCOR)(9) and autoinhibitory activity.(10) ETV6 plays an important role in hematopoiesis.”
Cited by
Whole-genome sequencing of patients with rare diseases in a national health system
Turro, E., Astle, W. J., Megy, K., Gräf, S., Greene, D., Shamardina, O., Allen, H. L., Sanchis-Juan, A., Frontini, M., Thys, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2434-2 · Cited by 554
Self-citationRho GTPases and their downstream effectors in megakaryocyte biology.
Pleines, I., Cherpokova, D., & Bender, M. (2019) · Platelets · doi:10.1080/09537104.2018.1478071 · Cited by 28
Metadata
- Authors
- Poggi, M., Canault, M., Favier, M., Turro, E., Saultier, P., Ghalloussi, D., Baccini, V., Vidal, L., Mezzapesa, A., Chelghoum, N., Mohand-Oumoussa, B., Falaise, C., Favier, R., Ouwehand, W. H., Fiore, M., Peiretti, F., Morange, P. E., Saut, N., Bernot, D., Greinacher, A., BioResource, N., Nurden, A. T., Nurden, P., Freson, K., Trégouët, D.-A., Raslova, H., & Alessi, M.-C.
- Venue
- Haematologica
- Published
- 2016-09-23
- Volume
- 102
- Issue
- 2
- Pages
- 282-294
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2522150123
- Cited by
- 96
- References
- 7
- FWCI
- 8.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.